US 12337199
Stable antibody formulation
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12337199 (Stable antibody formulation) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 63
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39591, A61K39/42